Cyclerion Therapeutics (CYCN) Cash from Investing Activities (2018 - 2023)

Cyclerion Therapeutics' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $10.4 million for Q3 2023.

• In Q3 2023, Cash from Investing Activities changed N/A year-over-year to $10.4 million; the TTM figure through Dec 2024 stood at $10.4 million (changed 0.0% YoY), while the FY2023 annual figure was $10.4 million, changed N/A from the prior year.
• Cash from Investing Activities for Q3 2023 stood at $10.4 million, up from -$7000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $10.4 million in Q3 2023, with the low at -$4.2 million in Q2 2019.
• The 4-year median for Cash from Investing Activities is -$36000.0 (2020), against an average of $430166.7.
• The sharpest annual moves came in 2019 and 2020: Cash from Investing Activities plunged 1315.67% in 2019, then surged 1536.0% in 2020.
• Cyclerion Therapeutics' Cash from Investing Activities stood at -$100000.0 in 2019, then soared by 1536.0% to $1.4 million in 2020, then slumped by 100.49% to -$7000.0 in 2021, then surged by 148700.0% to $10.4 million in 2023.
• Business Quant data shows CYCN's Cash from Investing Activities at $10.4 million in Q3 2023, -$7000.0 in Q3 2021, and $2000.0 in Q2 2021.